14.07
+0.54
+(3.99%)
At close: April 17 at 4:00:02 PM EDT
14.07
0.00
(0.00%)
After hours: April 17 at 7:47:11 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
615,886
370,025
306,781
255,251
Total Liabilities Net Minority Interest
44,333
37,812
29,358
12,077
Total Equity Gross Minority Interest
571,553
332,213
277,423
243,174
Total Capitalization
571,553
332,213
277,423
243,174
Common Stock Equity
571,553
332,213
277,423
243,174
Capital Lease Obligations
18,861
14,444
13,266
1,093
Net Tangible Assets
571,553
332,213
277,423
243,174
Working Capital
561,443
322,920
269,220
239,594
Invested Capital
571,553
332,213
277,423
243,174
Tangible Book Value
571,553
332,213
277,423
243,174
Total Debt
18,861
14,444
13,266
1,093
Share Issued
40,554.71
31,841.08
27,543.45
23,974.83
Ordinary Shares Number
40,554.71
31,841.08
27,543.45
23,974.83
12/31/2021 - 4/8/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
THRD Third Harmonic Bio, Inc.
5.16
+0.58%
KTTA Pasithea Therapeutics Corp.
1.3800
+0.73%
ELAB PMGC Holdings Inc.
2.6000
+0.78%
THTX Theratechnologies Inc.
2.5200
-1.95%
CYTK Cytokinetics, Incorporated
39.48
+0.84%
PHIO Phio Pharmaceuticals Corp.
2.7300
+1.11%
CDT Conduit Pharmaceuticals Inc.
0.6201
-20.51%
BCTX BriaCell Therapeutics Corp.
4.2900
-4.24%
MTVA MetaVia Inc.
0.7390
+0.91%
VERV Verve Therapeutics, Inc.
4.5900
+1.77%